Skip to main content
رجوع
Watch Compare

Emergent BioSolutions Inc.

جودة البيانات: 100%
EBS
NYSE Manufacturing Chemicals
KWD 7.96
▼ KWD 0.49 (-5.80%)
القيمة السوقية: 436.95 M
السعر
KWD 8.44
القيمة السوقية
436.95 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Revenue declined -19.77% annually over 5 years
Generating 156.80 M in free cash flow
P/E of 8.31 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.04%
Cash machine — converts 298.10% of earnings into free cash flow
Capital efficient — spends only 1.86% of revenue on capex

النمو

Revenue Growth (5Y)
-19.77%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-28.81%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
9.40%
أعلى من متوسط القطاع (-53.41%)
ROIC4.86%
Net Margin7.08%
Op. Margin13.47%

الأمان

Debt / Equity
1.19
أعلى من متوسط القطاع (0.31)
Current Ratio5.76
Interest Coverage1.69

التقييم

PE (TTM)
8.31
أعلى من متوسط القطاع (-1.48)
P/B Ratio0.75
EV/EBITDA4.52
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E 8.3 -1.5
P/B 0.8 1.6
ROE % 9.4 -53.4
Net Margin % 7.1 -41.5
Rev Growth 5Y % -19.8 1.8
D/E 1.2 0.3

ETFs Holding This Stock

AIFFX AIFFX
3.31% weight
ARIFX ARIFX
3.31% weight
BAHAX BAHAX
2.69% weight
BAFHX BAFHX
2.69% weight
ICPY logo ICPY Tweedy, Browne International Insider + Value ETF
1.91% weight
AIOOX AIOOX
1.67% weight
ARAOX ARAOX
1.67% weight
ARIOX ARIOX
1.67% weight
BINV BINV
1.67% weight
ACVDX ACVDX
1.52% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -28.81% Revenue Growth (3Y) -15.86%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -19.77% Earnings Growth (5Y) -30.91%
Profitability
Revenue (TTM) 742.90 M Net Income (TTM) 52.60 M
ROE 9.40% ROA 3.66%
Gross Margin N/A Operating Margin 13.47%
Net Margin 7.08% Free Cash Flow (TTM) 156.80 M
ROIC 4.86% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.19 Current Ratio 5.76
Interest Coverage 1.69 Asset Turnover 0.52
Working Capital 650.40 M Tangible Book Value 129.80 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 8.31 Forward P/E N/A
P/B Ratio 0.75 P/S Ratio 0.59
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 4.52 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 35.89%
Market Cap 436.95 M Enterprise Value 884.55 M
Per Share
EPS (Diluted TTM) 0.93 Revenue / Share 14.35
FCF / Share 3.03 OCF / Share 3.30
EPS CAGR (1Y) N/A EPS CAGR (5Y) -31.69%
EPS CAGR (10Y) -2.14%
Efficiency
CapEx / Revenue 1.86% FCF Conversion 298.10%
SBC-Adj. FCF 140.00 M Growth Momentum -9.04

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 742.90 M 1.04 B 1.05 B 1.12 B 1.79 B
Net Income 52.60 M -190.60 M -760.50 M -223.80 M 230.90 M
EPS (Diluted) 0.93 -3.60 -14.85 -4.47 4.27
Gross Profit — — 317.60 M 385.80 M —
Operating Income 100.10 M -108.70 M -726.40 M -172.70 M 352.60 M
EBITDA — — — — —
R&D Expenses 53.20 M 70.70 M 111.40 M 193.00 M 234.00 M
SG&A Expenses 186.10 M 308.00 M 368.40 M 340.30 M 348.40 M
D&A 95.80 M 108.80 M 125.10 M — —
Interest Expense 59.30 M 71.00 M 87.90 M 37.30 M 34.50 M
Income Tax 30.20 M 47.70 M 29.30 M 2.10 M 83.50 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.32 B 1.39 B 1.82 B 3.17 B 2.96 B
Total Liabilities 796.00 M 906.90 M 1.17 B 1.78 B 1.34 B
Shareholders' Equity 522.60 M 482.80 M 649.30 M 1.38 B 1.62 B
Total Debt 589.70 M 700.00 M 868.40 M 1.41 B 849.60 M
Cash & Equivalents 205.40 M 99.50 M 111.70 M 642.60 M 576.10 M
Current Assets 662.50 M 598.70 M 679.50 M 1.21 B 1.27 B
Current Liabilities 132.20 M 162.40 M 651.30 M 1.23 B 373.80 M